Glyset
OVERDOSE
Unlike sulfonylureas or insulin, an overdose of GLYSET Tablets will not result in hypoglycemia. An overdose may result in transient increases in flatulence, diarrhea, and abdominal discomfort. Because of the lack of extra-intestinal effects seen with GLYSET, no serious systemic reactions are expected in the event of an overdose.
CONTRAINDICATIONS
GLYSET Tablets are contraindicated in patients with:
- Diabetic ketoacidosis
- Inflammatory bowel disease, colonic ulceration, or partial intestinal obstruction, and in patients predisposed to intestinal obstruction
- Chronic intestinal diseases associated with marked disorders of digestion or absorption, or with conditions that may deteriorate as a result of increased gas formation in the intestine
- Hypersensitivity to the drug or any of its components.
Generic Name: Miglitol
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Diabetes
Find tips and advances in treatment.
Health Extras
Living with an Insulin Pump
After years of debilitating seizures, diabetic Melissa Jeffries regains control of her diabetes through the use of an insulin pump. See more WebMD Videos »
Glyset
Related Drugs
Health Resources
Updated & New
RxList does not provide medical advice, diagnosis or treatment.